The primary mechanism underlying the efficacy of these drugs involves regulating the Nrf2/HO-1 pathway, which helps to reduce ROS content in MI mice and promote SOD expression, thereby protecting myocardial cells from oxidative stress damage. This evidence concerns the gene HMOX1 and myocardial infarction.